FARN — Faron Pharmaceuticals Oy Share News
0.000.00%
Last trade - 00:00- £225.44m
- £227.66m
REG - Faron Pharma. Oy - FDA Grants Fast Track Designation for Bexmarilimab
AnnouncementREG - Faron Pharma. Oy - Faron 2024 Half-Year Financial Results
AnnouncementREG - Faron Pharma. Oy - Notice of Half-Year Financial Results
AnnouncementRCS - Faron Pharma. Oy - Traumakine Research Collaboration and DoD Grant
AnnouncementREG - Faron Pharma. Oy - Appointment of Chief Financial Officer
AnnouncementREG - Faron Pharma. Oy - Grant of options
AnnouncementREG - Faron Pharma. Oy - Faron Appoints Dr. Petri Bono as new CMO
AnnouncementREG - Faron Pharma. Oy - Faron Announces Positive FDA Feedback
AnnouncementREG - Faron Pharma. Oy - Update on settlement
AnnouncementREG - Faron Pharma. Oy - Holding(s) in Company
AnnouncementREG - Faron Pharma. Oy - Holding(s) in Company
AnnouncementREG - Faron Pharma. Oy - Holding(s) in Company
AnnouncementREG - Faron Pharma. Oy - Holding(s) in Company
AnnouncementREG - AIM - AIM Notice - 24/06/2024
AnnouncementREG - Faron Pharma. Oy - New shares registered with Finnish Trade Register
AnnouncementREG - Faron Pharma. Oy - Fully subscribed EUR 30.7 million share offering
AnnouncementREG - Faron Pharma. Oy - Proposed REX Retail Offer
AnnouncementREG - Faron Pharma. Oy - Faron commences a share offering
AnnouncementREG - Faron Pharma. Oy - Initial positive data from Phase 2 of BEXMAB
Announcement